Altamira Therapeutics Provides Business Update

Provided By GlobeNewswire

Last update: May 28, 2024

Hamilton, Bermuda, May 28, 2024 (GLOBE NEWSWIRE) --

HAMILTON, BERMUDA / May 28, 2024 / Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today provided a business update related to its RNA delivery platform, partnering of its legacy assets, corporate structuring and financial reporting.